Amneal Oncology Profile
Key Indicators
- Authorised Capital ₹ 35.00 Cr
- Paid Up Capital ₹ 33.65 Cr
- Company Age 26 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 58.32 Cr
- Revenue Growth -10.36%
- Profit Growth 28.81%
- Ebitda -24.49%
- Net Worth 7.11%
- Total Assets -6.52%
About Amneal Oncology
Amneal Oncology Private Limited (AOPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 10 November 1998 and has a history of 26 years and two months. Its registered office is in Ahmedabad, Gujarat, India.
The Corporate was formerly known as Epsilon Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 35.00 Cr and a paid-up capital of Rs 33.65 Cr.
The company has closed loans amounting to ₹58.32 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Amneal Oncology Private Limited India is Ekta Joshi as COMPANY SECRETARY. Suresh Patel and Rajeev Midha serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24230GJ1998PTC084755
- Company No.
084755
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Nov 1998
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Amneal Oncology?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ekta Joshi  | Company Secretary | 07-Apr-2023 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajeev Midha | Director | 25-Jan-2019 | Current |
| Suresh Patel | Director | 01-Dec-2014 | Current |
Financial Performance of Amneal Oncology.
Amneal Oncology Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 10.36% decrease. The company also saw a substantial improvement in profitability, with a 28.81% increase in profit. The company's net worth moved up by a moderate rise of 7.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Amneal Oncology?
In 2023, Amneal Oncology had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Wheels India Niswarth FoundationSuresh Patel is a mutual person
Raks Pharma Private LimitedSuresh Patel and Rajeev Midha are mutual person
Kashiv Biosciences Private LimitedSuresh Patel is a mutual person
Amneal Healthcare Private LimitedSuresh Patel and Rajeev Midha are mutual person
Amneal Pharmaceuticals Private LimitedEkta Joshi, Suresh Patel and 1 more are mutual person
Shivanka Research Private LimitedSuresh Patel is a mutual person
Charges (Loans)
₹0
₹58.32 Cr
Charges Breakdown by Lending Institutions
- Vijaya Bank (Lead Bank) : 58.21 Cr
- Vijaya Bank : 0.11 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Dec 2011 | Vijaya Bank (Lead Bank) | ₹58.21 Cr | Satisfied |
| 24 Feb 2011 | Vijaya Bank | ₹1.09 M | Satisfied |
How Many Employees Work at Amneal Oncology?
Amneal Oncology has a workforce of 262 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amneal Oncology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amneal Oncology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
